Clonal Lentivirus Packaging Cell Lines for Low-Recombination Libraries

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing lentiviral vector systems suffer from high rates of genetic recombination between library elements, limiting the complexity and sensitivity of functional genomic screens.

Innovation Solution

Employing a lentivirus-producing cell line with a transduction targeting element and serine recombinase system to ensure each cell produces only a single type of viral particle, using site-specific recombination to integrate and express identical viral mRNA or DNA, thereby preventing recombination.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If multiple variable sequences are integrated into lentiviral vectors for combinatorial perturbations, then the complexity of functional genomic screens is increased, but recombination between library elements occurs at high rates

Engineering Contradiction:
Improvelibrary complexityVSAvoidrecombination rate
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent divides the lentiviral vector system into separate functional modules: a stable integrating backbone containing the serine recombinase and attB sites, and separate transfer vectors containing the variable library elements. This segmentation ensures that only one variable sequence is integrated per cell, preventing recombination between multiple library elements while maintaining high library complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent performs preliminary integration of the serine recombinase and attB recognition sites into the host cell genome before introducing the variable library elements. This preliminary action creates a controlled landing pad that directs subsequent integration events, ensuring that each cell receives only a single variable sequence and eliminating the recombination problem that occurs when multiple sequences are integrated simultaneously.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If lentiviral plasmids are diluted with non-integrating plasmid DNA to limit multiple integrations, then the viral titer decreases by 100-fold

Engineering Contradiction:
Improvesingle integration controlVSAvoidviral titer
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent extracts the serine recombinase system and attB sites from the variable library vectors and places them in a separate stable integrating plasmid. This extraction allows the variable library vectors to be used at full concentration without the need for dilution, as the recombination system is already present in the host cell and will direct single-copy integration of the library elements.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces the serine recombinase as an intermediary enzyme that mediates site-specific recombination between the attB sites in the host genome and the attP sites in the library vectors. This intermediary mechanism provides precise control over integration events without requiring plasmid dilution, maintaining both high viral titer and single-integration fidelity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If library elements are spaced widely with regulatory sequences or barcodes, then the functional utility is improved, but recombination events increase beyond 30%

Engineering Contradiction:
Improvefunctional utilityVSAvoidrecombination frequency
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent applies local quality by creating distinct functional zones: the attB recognition sites serve as localized integration targets with defined boundaries, while the variable library elements with their regulatory sequences and barcodes are contained within the recombination cassette. This localized organization ensures that recombination occurs only at the defined attB-attP interfaces, not within the spaced library elements themselves, maintaining both functional utility and low recombination rates.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables large-scale, high-throughput functional genomic screens with complex libraries by ensuring each viral particle carries identical genetic payloads, reducing recombination events and enhancing screening sensitivity.

Implementation Method 1

employing a lentivirus-producing cell line with a transduction targeting element and serine recombinase system to ensure each cell produces only a single type of viral particle, using site-specific recombination to integrate and express identical viral mRNA or DNA

Methodology Applied
Scientific EffectSite-specific recombination: Enzyme

Data Source

PatentUS20250313829A1Compositions comprising cell lines and methods of generating viral particles using the same
Publication Date: 2025.10.09 RGT UNIV OF CALIFORNIA
  • US20250313829A1 patent drawing
  • US20250313829A1 patent drawing
  • US20250313829A1 patent drawing

AI summary

The disclosure provides novel virus packaging elements and cells transduced by such elements to enable large-scale library screens with combinatorial elements that heretofore were impractical due to the presence of recombination between library elements that occurs during conventional lentivirus production and transduction of target cells. The present disclosure overcomes these problems by generating clonal virus packaging cells that each produce a genetically homologous virus.